| Trisomy 21 dysregulates T cell lineages toward an autoimmunity-prone state associated with interferon hyperactivity P Araya, KA Waugh, KD Sullivan, NG Núñez, E Roselli, KP Smith, ... Proceedings of the National Academy of Sciences 116 (48), 24231-24241, 2019 | 104 | 2019 |
| Insight into next-generation CAR therapeutics: designing CAR T cells to improve clinical outcomes E Roselli, R Faramand, ML Davila The Journal of Clinical Investigation 131 (2), 2021 | 69 | 2021 |
| Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8+ T Cells upon Stimulation with a TLR7 Ligand ER Zacca, MI Crespo, RP Acland, E Roselli, NG Núñez, M Maccioni, ... PloS one 10 (10), e0140672, 2015 | 60 | 2015 |
| 4-1BB and optimized CD28 co-stimulation enhances function of human mono-specific and bi-specific third-generation CAR T cells E Roselli, JC Boucher, G Li, H Kotani, K Spitler, K Reid, EV Cervantes, ... Journal for immunotherapy of cancer 9 (10), 2021 | 54 | 2021 |
| Photodynamic modulation of type 1 interferon pathway on melanoma cells promotes dendritic cell activation MJ Lamberti, FM Mentucci, E Roselli, P Araya, VA Rivarola, ... Frontiers in immunology 10, 484842, 2019 | 36 | 2019 |
| TLR3 Activation of Intratumoral CD103+ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity E Roselli, P Araya, NG Núñez, G Gatti, F Graziano, C Sedlik, P Benaroch, ... Frontiers in immunology 10, 503, 2019 | 33 | 2019 |
| CAR-T engineering: optimizing signal transduction and effector mechanisms E Roselli, JS Frieling, K Thorner, MC Ramello, CC Lynch, D Abate-Daga BioDrugs 33, 647-659, 2019 | 28 | 2019 |
| High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer G Gatti, C Betts, D Rocha, M Nicola, V Grupe, C Ditada, NG Nuñez, ... Breast Cancer Research 23, 1-15, 2021 | 19 | 2021 |
| In vivo visualizing the IFN-β response required for tumor growth control in a therapeutic model of polyadenylic-polyuridylic acid administration DA Nocera, E Roselli, P Araya, NG Nunez, S Lienenklaus, J Jablonska, ... The Journal of Immunology 196 (6), 2860-2869, 2016 | 16 | 2016 |
| γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer JS Frieling, L Tordesillas, XE Bustos, MC Ramello, RT Bishop, JE Cianne, ... Science advances 9 (18), eadf0108, 2023 | 12 | 2023 |
| Downregulation of adaptor protein MyD88 compromises the angiogenic potential of B16 murine melanoma LD Trucco, E Roselli, P Araya, NG Nuñez, HA Mena, JL Bocco, S Negrotto, ... PloS one 12 (6), e0179897, 2017 | 7 | 2017 |
| 105 4–1BB and optimized CD28 co-stimulation enhances function of human mono-and bi-specific third-generation CAR T cells E Roselli, J Boucher, G Li, H Kotani, K Spitler, K Reid, Y Bulliard, N Tu, ... Journal for ImmunoTherapy of Cancer 9 (Suppl 2), 2021 | | 2021 |
| Bivalent CD19/CD20-Specific CAR T Cells with 4-1BB and Mutated CD28 Co-Stimulatory Domains Show Enhanced Function E Roselli, G Li, K Spitler, J Boucher, KM Reid, SB Lee, N Tu, ML Davila MOLECULAR THERAPY 29 (4), 74-75, 2021 | | 2021 |
| Costimulation with Mutated CD28 and 41BB Enhances Human CAR T Cell Function JC Boucher, E Roselli, E Cervantes, K Reid, K Spitler, ML Davila MOLECULAR THERAPY 29 (4), 310-311, 2021 | | 2021 |
| Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer G Gatti, C Betts, D Rocha, M Nicola, V Grupe, C Ditada, NG Nuñez, ... Breast Cancer Research: BCR 23, 2021 | | 2021 |
| The length of the intracellular domain conditions the antitumor efficacy of CAR-T cells MC Ramello, E Roselli, D Abate-Daga The Journal of Immunology 204 (1_Supplement), 170.20-170.20, 2020 | | 2020 |
| gamma delta CAR-T cell therapy for bone metastatic castrate resistant prostate cancer JS Frieling, E Roselli, MC Ramello, CH Lo, I Benzaid, CC Lynch, ... HUMAN GENE THERAPY 30 (11), A68-A68, 2019 | | 2019 |
| γδ CAR T-cell therapy significantly mitigates bone metastatic castrate-resistant prostate cancer JS Frieling, MC Ramello, I Benzaid, E Roselli, CH Lo, CC Lynch, ... Cancer Research 79 (13_Supplement), 934-934, 2019 | | 2019 |
| gamma delta CAR-T Cells Show Dual CAR-and TCR-Mediated Mechanisms of Tumor Cell Recognition against Bone Metastatic Castrate Resistant Prostate Cancer E Roselli, I Benzaid, JS Frieling, CM Ramello, CC Lynch, D Abate-Daga MOLECULAR THERAPY 27 (4), 320-321, 2019 | | 2019 |
| In vivo visualizing the IFN-beta response required for tumor growth control in a therapeutic model of poly A: U administration M Maccioni, M Brinkmann, P Araya, J Jablonska, E Roselli, DA Nocera, ... EUROPEAN JOURNAL OF IMMUNOLOGY 46, 40-41, 2016 | | 2016 |
Nicolas NuñezPhDVerified email at immunology.uzh.ch
